|
1
|
Wilhelm I, Molnár J, Fazakas C, Haskó J
and Krizbai IA: Role of the blood-brain barrier in the formation of
brain metastases. Int J Mol Sci. 14:1383–1411. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Walker AE, Robins M and Weinfeld FD:
Epidemiology of brain tumors: the national survey of intracranial
neoplasms. Neurology. 35:219–226. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gavrilovic IT and Posner JB: Brain
metastases: epidemiology and pathophysiology. J Neurooncol.
75:5–14. 2005. View Article : Google Scholar
|
|
4
|
Schouten LJ, Rutten J, Huveneers HA and
Twijnstra A: Incidence of brain metastases in a cohort of patients
with carcinoma of the breast, colon, kidney, and lung and melanoma.
Cancer. 94:2698–2705. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Preusser M, Capper D, Ilhan-Mutlu A, et
al: Brain metastases: pathobiology and emerging targeted therapies.
Acta Neuropathol. 123:205–222. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Barnholtz-Sloan JS, Sloan AE, Davis FG,
Vigneau FD, Lai P and Sawaya RE: Incidence proportions of brain
metastases in patients diagnosed (1973 to 2001) in the Metropolitan
Detroit Cancer Surveillance System. J Clin Oncol. 22:2865–2872.
2004. View Article : Google Scholar
|
|
7
|
Platta CS, Khuntia D, Mehta MP and Suh JH:
Current treatment strategies for brain metastasis and complications
from therapeutic techniques: a review of current literature. Am J
Clin Oncol. 33:398–407. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lim LC, Rosenthal MA, Maartens N and Ryan
G: Management of brain metastases. Intern Med J. 34:270–278. 2004.
View Article : Google Scholar
|
|
9
|
Lu-Emerson C and Eichler AF: Brain
metastases. Continuum (Minneap Minn). 18:295–311. 2012.PubMed/NCBI
|
|
10
|
Delattre JY, Krol G, Thaler HT and Posner
JB: Distribution of brain metastases. Arch Neurol. 45:741–744.
1988. View Article : Google Scholar
|
|
11
|
Gaspar LE, Mehta MP, Patchell RA, et al:
The role of whole brain radiation therapy in the management of
newly diagnosed brain metastases: a systematic review and
evidence-based clinical practice guideline. J Neurooncol. 96:17–32.
2010. View Article : Google Scholar
|
|
12
|
Linskey ME, Andrews DW, Asher AL, et al:
The role of stereotactic radiosurgery in the management of patients
with newly diagnosed brain metastases: a systematic review and
evidence-based clinical practice guideline. J Neurooncol. 96:45–68.
2010. View Article : Google Scholar
|
|
13
|
Mehta MP, Paleologos NA, Mikkelsen T, et
al: The role of chemotherapy in the management of newly diagnosed
brain metastases: a systematic review and evidence-based clinical
practice guideline. J Neurooncol. 96:71–83. 2010. View Article : Google Scholar
|
|
14
|
Kalkanis SN, Kondziolka D, Gaspar LE, et
al: The role of surgical resection in the management of newly
diagnosed brain metastases: a systematic review and evidence-based
clinical practice guideline. J Neurooncol. 96:33–43. 2010.
View Article : Google Scholar
|
|
15
|
Olson JJ, Paleologos NA, Gaspar LE, et al:
The role of emerging and investigational therapies for metastatic
brain tumors: a systematic review and evidence-based clinical
practice guideline of selected topics. J Neurooncol. 96:115–142.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fokas E, Steinbach JP and Rödel C: Biology
of brain metastases and novel targeted therapies: time to translate
the research. Biochim Biophys Acta. 1835:61–75. 2013.PubMed/NCBI
|
|
17
|
Correale J and Villa A: Cellular elements
of the blood-brain barrier. Neurochem Res. 34:2067–2077. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bearer EL and Orci L: Endothelial
fenestral diaphragms: a quick-freeze, deep-etch study. J Cell Biol.
100:418–428. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Brightman MW and Reese TS: Junctions
between intimately apposed cell membranes in the vertebrate brain.
J Cell Biol. 40:648–677. 1969. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Lane NJ, Reese TS and Kachar B: Structural
domains of the tight junctional intramembrane fibrils. Tissue Cell.
24:291–300. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Villegas JC and Broadwell RD: Transcytosis
of protein through the mammalian cerebral epithelium and
endothelium. II Adsorptive transcytosis of WGA-HRP and the
blood-brain and brain-blood barriers. J Neurocytol. 22:67–80. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dorovini-Zis K, Prameya R and Bowman PD:
Culture and characterization of microvascular endothelial cells
derived from human brain. Lab Invest. 64:425–436. 1991.PubMed/NCBI
|
|
23
|
Armulik A, Abramsson A and Betsholtz C:
Endothelial/pericyte interactions. Circ Res. 97:512–523. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Winkler EA, Bell RD and Zlokovic BV:
Central nervous system pericytes in health and disease. Nat
Neurosci. 14:1398–1405. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dalkara T, Gursoy-Ozdemir Y and Yemisci M:
Brain microvascular pericytes in health and disease. Acta
Neuropathol. 122:1–9. 2011. View Article : Google Scholar
|
|
26
|
Kacem K, Lacombe P, Seylaz J and Bonvento
G: Structural organization of the perivascular astrocyte endfeet
and their relationship with the endothelial glucose transporter: a
confocal microscopy study. Glia. 23:1–10. 1998. View Article : Google Scholar
|
|
27
|
Cohen Z, Molinatti G and Hamel E:
Astroglial and vascular interactions of noradrenaline terminals in
the rat cerebral cortex. J Cereb Blood Flow Metab. 17:894–904.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Paspalas CD and Papadopoulos GC:
Ultrastructural relationships between noradrenergic nerve fibers
and non-neuronal elements in the rat cerebral cortex. Glia.
17:133–146. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhao YN, Wang F, Fan YX, Ping GF, Yang JY
and Wu CF: Activated microglia are implicated in cognitive
deficits, neuronal death, and successful recovery following
intermittent ethanol exposure. Behav Brain Res. 236:270–282. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Readnower RD, Chavko M, Adeeb S, et al:
Increase in blood-brain barrier permeability, oxidative stress, and
activated microglia in a rat model of blast-induced traumatic brain
injury. J Neurosci Res. 88:3530–3539. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rascher G, Fischmann A, Kröger S, Duffner
F, Grote EH and Wolburg H: Extracellular matrix and the blood-brain
barrier in glioblastoma multiforme: spatial segregation of tenascin
and agrin. Acta Neuropathol. 104:85–91. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Jian Liu K and Rosenberg GA: Matrix
metalloproteinases and free radicals in cerebral ischemia. Free
Radic Biol Med. 39:71–80. 2005.PubMed/NCBI
|
|
33
|
Abbott NJ, Patabendige AA, Dolman DE,
Yusof SR and Begley DJ: Structure and function of the blood-brain
barrier. Neurobiol Dis. 37:13–25. 2010. View Article : Google Scholar
|
|
34
|
Wilhelm I, Fazakas C and Krizbai IA: In
vitro models of the blood-brain barrier. Acta Neurobiol Exp (Wars).
71:113–128. 2011.PubMed/NCBI
|
|
35
|
Furuse M, Hirase T, Itoh M, Nagafuchi A,
Yonemura S and Tsukita S and Tsukita S: Occludin: a novel integral
membrane protein localizing at tight junctions. J Cell Biol.
123:1777–1788. 1993. View Article : Google Scholar
|
|
36
|
Liu WY, Wang ZB, Zhang LC, Wei X and Li L:
Tight junction in blood-brain barrier: an overview of structure,
regulation, and regulator substances. CNS Neurosci Ther.
18:609–615. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Luissint AC, Artus C, Glacial F,
Ganeshamoorthy K and Couraud PO: Tight junctions at the blood brain
barrier: physiological architecture and disease-associated
dysregulation. Fluids Barriers CNS. 9:232012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Feldman GJ, Mullin JM and Ryan MP:
Occludin: structure, function and regulation. Adv Drug Deliv Rev.
57:883–917. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Förster C: Tight junctions and the
modulation of barrier function in disease. Histochem Cell Biol.
130:55–70. 2008.PubMed/NCBI
|
|
40
|
Langer HF, Orlova VV, Xie C, et al: A
novel function of junctional adhesion molecule-C in mediating
melanoma cell metastasis. Cancer Res. 71:4096–4105. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Furuse M, Fujita K, Hiiragi T, Fujimoto K
and Tsukita S: Claudin-1 and -2: novel integral membrane proteins
localizing at tight junctions with no sequence similarity to
occludin. J Cell Biol. 141:1539–1550. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lal-Nag M and Morin PJ: The claudins.
Genome Biol. 10:2352009. View Article : Google Scholar
|
|
43
|
Gumbiner B, Lowenkopf T and Apatira D:
Identification of a 160-kDa polypeptide that binds to the tight
junction protein ZO-1. Proc Natl Acad Sci USA. 88:3460–3464. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Stevenson BR, Siliciano JD, Mooseker MS
and Goodenough DA: Identification of ZO-1: a high molecular weight
polypeptide associated with the tight junction (zonula occludens)
in a variety of epithelia. J Cell Biol. 103:755–766. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Haskins J, Gu L, Wittchen ES, Hibbard J
and Stevenson BR: ZO-3, a novel member of the MAGUK protein family
found at the tight junction, interacts with ZO-1 and occludin. J
Cell Biol. 141:199–208. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Blackman B, Russell T, Nordeen SK, Medina
D and Neville MC: Claudin 7 expression and localization in the
normal murine mammary gland and murine mammary tumors. Breast
Cancer Res. 7:R248–R255. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
47
|
Morin PJ: Claudin proteins in human
cancer: promising new targets for diagnosis and therapy. Cancer
Res. 65:9603–9606. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Colegio OR, Van Itallie CM, McCrea HJ,
Rahner C and Anderson JM: Claudins create charge-selective channels
in the paracellular pathway between epithelial cells. Am J Physiol
Cell Physiol. 283:C142–C147. 2002. View Article : Google Scholar
|
|
49
|
Angelow S, Ahlstrom R and Yu AS: Biology
of claudins. Am J Physiol Renal Physiol. 295:F867–F876. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Piontek J, Winkler L, Wolburg H, et al:
Formation of tight junction: determinants of homophilic interaction
between classic claudins. FASEB J. 22:146–158. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Piehl C, Piontek J, Cording J, Wolburg H
and Blasig IE: Participation of the second extracellular loop of
claudin-5 in paracellular tightening against ions, small and large
molecules. Cell Mol Life Sci. 67:2131–2140. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hamazaki Y, Itoh M, Sasaki H, Furuse M and
Tsukita S: Multi-PDZ domain protein 1 (MUPP1) is concentrated at
tight junctions through its possible interaction with claudin-1 and
junctional adhesion molecule. J Biol Chem. 277:455–461. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Roh MH, Liu CJ, Laurinec S and Margolis B:
The carboxyl terminus of zona occludens-3 binds and recruits a
mammalian homologue of discs lost to tight junctions. J Biol Chem.
277:27501–27509. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Itoh M, Furuse M, Morita K, Kubota K,
Saitou M and Tsukita S: Direct binding of three tight
junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH
termini of claudins. J Cell Biol. 147:1351–1363. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Rüffer C and Gerke V: The C-terminal
cytoplasmic tail of claudins 1 and 5 but not its PDZ-binding motif
is required for apical localization at epithelial and endothelial
tight junctions. Eur J Cell Biol. 83:135–144. 2004.PubMed/NCBI
|
|
56
|
Van Itallie CM, Colegio OR and Anderson
JM: The cytoplasmic tails of claudins can influence tight junction
barrier properties through effects on protein stability. J Membr
Biol. 199:29–38. 2004.PubMed/NCBI
|
|
57
|
Mitic LL, Unger VM and Anderson JM:
Expression, solubilization, and biochemical characterization of the
tight junction transmembrane protein claudin-4. Protein Sci.
12:218–227. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Blasig IE, Winkler L, Lassowski B, et al:
On the self-association potential of transmembrane tight junction
proteins. Cell Mol Life Sci. 63:505–514. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Furuse M, Sasaki H and Tsukita S: Manner
of interaction of heterogeneous claudin species within and between
tight junction strands. J Cell Biol. 147:891–903. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Daugherty BL, Ward C, Smith T,
Ritzenthaler JD and Koval M: Regulation of heterotypic claudin
compatibility. J Biol Chem. 282:30005–30013. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Coyne CB, Gambling TM, Boucher RC, Carson
JL and Johnson LG: Role of claudin interactions in airway tight
junctional permeability. Am J Physiol Lung Cell Mol Physiol.
285:L1166–L1178. 2003.PubMed/NCBI
|
|
62
|
Ward C and Koval M: Biochemical analysis
of claudin-binding compatibility. Methods Mol Biol. 762:13–26.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Gupta IR and Ryan AK: Claudins: unlocking
the code to tight junction function during embryogenesis and in
disease. Clin Genet. 77:314–325. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Cooper I, Cohen-Kashi-Malina K and
Teichberg VI: Claudin-5 expression in in vitro models of the
blood-brain barrier. Methods Mol Biol. 762:347–354. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Neuhaus W, Wirth M, Plattner VE, Germann
B, Gabor F and Noe CR: Expression of Claudin-1, Claudin-3 and
Claudin-5 in human blood-brain barrier mimicking cell line ECV304
is inducible by glioma-conditioned media. Neurosci Lett. 446:59–64.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Ohtsuki S, Yamaguchi H, Katsukura Y,
Asashima T and Terasaki T: mRNA expression levels of tight junction
protein genes in mouse brain capillary endothelial cells highly
purified by magnetic cell sorting. J Neurochem. 104:147–154.
2008.
|
|
67
|
Ohtsuki S, Sato S, Yamaguchi H, Kamoi M,
Asashima T and Terasaki T: Exogenous expression of claudin-5
induces barrier properties in cultured rat brain capillary
endothelial cells. J Cell Physiol. 210:81–86. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Nitta T, Hata M, Gotoh S, et al:
Size-selective loosening of the blood-brain barrier in
claudin-5-deficient mice. J Cell Biol. 161:653–660. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Morita K, Sasaki H, Furuse M and Tsukita
S: Endothelial claudin: claudin-5/TMVCF constitutes tight junction
strands in endothelial cells. J Cell Biol. 147:185–194. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Morita K, Sasaki H, Furuse K, Furuse M,
Tsukita S and Miyachi Y: Expression of claudin-5 in dermal vascular
endothelia. Exp Dermatol. 12:289–295. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Rahner C, Mitic LL and Anderson JM:
Heterogeneity in expression and subcellular localization of
claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut.
Gastroenterology. 120:411–422. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Biazik JM, Thompson MB and Murphy CR:
Claudin-5 is restricted to the tight junction region of uterine
epithelial cells in the uterus of pregnant/gravid squamate
reptiles. Anat Rec (Hoboken). 291:547–556. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Amasheh S, Schmidt T, Mahn M, et al:
Contribution of claudin-5 to barrier properties in tight junctions
of epithelial cells. Cell Tissue Res. 321:89–96. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Ohtsuki S, Ikeda C, Uchida Y, et al:
Quantitative targeted absolute proteomic analysis of transporters,
receptors and junction proteins for validation of human cerebral
microvascular endothelial cell line hCMEC/D3 as a human blood-brain
barrier model. Mol Pharm. 10:289–296. 2013. View Article : Google Scholar
|
|
75
|
Wen H, Watry DD, Marcondes MC and Fox HS:
Selective decrease in paracellular conductance of tight junctions:
role of the first extracellular domain of claudin-5. Mol Cell Biol.
24:8408–8417. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Piontek J, Fritzsche S, Cording J, et al:
Elucidating the principles of the molecular organization of
heteropolymeric tight junction strands. Cell Mol Life Sci.
68:3903–3918. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Kluger MS, Clark PR, Tellides G, Gerke V
and Pober JS: Claudin-5 controls intercellular barriers of human
dermal microvascular but not human umbilical vein endothelial
cells. Arterioscler Thromb Vasc Biol. 33:489–500. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Yang Y and Rosenberg GA: MMP-mediated
disruption of claudin-5 in the blood-brain barrier of rat brain
after cerebral ischemia. Methods Mol Biol. 762:333–345. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
79
|
Liu C, Wu J and Zou MH: Activation of
AMP-activated protein kinase alleviates high-glucose-induced
dysfunction of brain microvascular endothelial cell tight-junction
dynamics. Free Radic Biol Med. 53:1213–1221. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Balbuena P, Li W and Ehrich M: Assessments
of tight junction proteins occludin, claudin 5 and scaffold
proteins ZO1 and ZO2 in endothelial cells of the rat blood-brain
barrier: cellular responses to neurotoxicants malathion and lead
acetate. Neurotoxicology. 32:58–67. 2011. View Article : Google Scholar
|
|
81
|
Helms HC, Waagepetersen HS, Nielsen CU and
Brodin B: Paracellular tightness and claudin-5 expression is
increased in the BCEC/astrocyte blood-brain barrier model by
increasing media buffer capacity during growth. AAPS J. 12:759–770.
2010. View Article : Google Scholar
|
|
82
|
Ishizaki T, Chiba H, Kojima T, et al:
Cyclic AMP induces phosphorylation of claudin-5 immunoprecipitates
and expression of claudin-5 gene in blood-brain-barrier endothelial
cells via protein kinase A-dependent and -independent pathways. Exp
Cell Res. 290:275–288. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Soma T, Chiba H, Kato-Mori Y, et al:
Thr(207) of claudin-5 is involved in size-selective loosening of
the endothelial barrier by cyclic AMP. Exp Cell Res. 300:202–212.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Yuan L, Le Bras A, Sacharidou A, et al:
ETS-related gene (ERG) controls endothelial cell permeability via
transcriptional regulation of the claudin 5 (CLDN5) gene. J Biol
Chem. 287:6582–6591. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Shen W, Li S, Chung SH, et al: Tyrosine
phosphorylation of VE-cadherin and claudin-5 is associated with
TGF-β1-induced permeability of centrally derived vascular
endothelium. Eur J Cell Biol. 90:323–332. 2011.PubMed/NCBI
|
|
86
|
Shimizu F, Sano Y, Saito K, et al:
Pericyte-derived glial cell line-derived neurotrophic factor
increase the expression of claudin-5 in the blood-brain barrier and
the blood-nerve barrier. Neurochem Res. 37:401–409. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
87
|
András IE and Toborek M: HIV-1-induced
alterations of claudin-5 expression at the blood-brain barrier
level. Methods Mol Biol. 762:355–370. 2011.PubMed/NCBI
|
|
88
|
András IE, Pu H, Tian J, et al: Signaling
mechanisms of HIV-1 Tat-induced alterations of claudin-5 expression
in brain endothelial cells. J Cereb Blood Flow Metab. 25:1159–1170.
2005.PubMed/NCBI
|
|
89
|
Liu LB, Xue YX, Liu YH and Wang YB:
Bradykinin increases blood-tumor barrier permeability by
down-regulating the expression levels of ZO-1, occludin, and
claudin-5 and rearranging actin cytoskeleton. J Neurosci Res.
86:1153–1168. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
90
|
Osada T, Gu YH, Kanazawa M, et al:
Interendothelial claudin-5 expression depends on cerebral
endothelial cell-matrix adhesion by β(1)-integrins. J Cereb Blood
Flow Metab. 31:1972–1985. 2011.PubMed/NCBI
|
|
91
|
Del Vecchio G, Tscheik C, Tenz K, et al:
Sodium caprate transiently opens claudin-5-containing barriers at
tight junctions of epithelial and endothelial cells. Mol Pharm.
9:2523–2533. 2012.PubMed/NCBI
|
|
92
|
Liebner S, Fischmann A, Rascher G, et al:
Claudin-1 and claudin-5 expression and tight junction morphology
are altered in blood vessels of human glioblastoma multiforme. Acta
Neuropathol. 100:323–331. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Chiba T, Kawachi H, Kawano T, et al:
Independent histological risk factors for lymph node metastasis of
superficial esophageal squamous cell carcinoma; implication of
claudin-5 immunohistochemistry for expanding the indications of
endoscopic resection. Dis Esophagus. 23:398–407. 2010.
|
|
94
|
Miyamori H, Takino T, Kobayashi Y, et al:
Claudin promotes activation of pro-matrix metalloproteinase-2
mediated by membrane-type matrix metalloproteinases. J Biol Chem.
276:28204–28211. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Stamatovic SM, Keep RF, Wang MM, Jankovic
I and Andjelkovic AV: Caveolae-mediated internalization of occludin
and claudin-5 during CCL2-induced tight junction remodeling in
brain endothelial cells. J Biol Chem. 284:19053–19066. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Stamatovic SM, Keep RF and Andjelkovic AV:
Tracing the endocytosis of claudin-5 in brain endothelial cells.
Methods Mol Biol. 762:303–320. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Escudero-Esparza A, Jiang WG and Martin
TA: Claudin-5 is involved in breast cancer cell motility through
the N-WASP and ROCK signalling pathways. J Exp Clin Cancer Res.
31:432012. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Yamamoto M, Ramirez SH, Sato S, et al:
Phosphorylation of claudin-5 and occludin by rho kinase in brain
endothelial cells. Am J Pathol. 172:521–533. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Persidsky Y, Heilman D, Haorah J, et al:
Rho-mediated regulation of tight junctions during monocyte
migration across the blood-brain barrier in HIV-1 encephalitis
(HIVE). Blood. 107:4770–4780. 2006. View Article : Google Scholar : PubMed/NCBI
|
